IT data communications business growth and acquisitions driven by dual engines, Amphenol (APH.US) Q3 results and Q4 guidance exceed expectations
Amphenol announced its third-quarter financial results.
Amphenol (APH.US) released its Q3 2026 results before the U.S. market open on Wednesday. Q3 net sales were $10.230 billion, up 65% year-over-year, above the market consensus of approximately $9.465 billion; organic growth was 37%, with constant-currency and USD figures consistent. Adjusted diluted EPS was $0.80, up 74% year-over-year, above the consensus of $0.72; GAAP diluted EPS was $0.79, up 61% year-over-year. The company said both sales and adjusted EPS exceeded the upper end of its prior guidance (adjusted EPS guidance had been $0.70 to $0.71).
The Communications Solutions segment posted sales of $6.583 billion, up 99% year-over-year, of which 48 percentage points came from acquisitions and organic growth was 51%; the company said the IT data communications market continued to show "exceptionally strong" organic growth. Harsh Environment Solutions sales were $2.042 billion, up 35% (organic 29%); Interconnect and Sensor Systems sales were $1.605 billion, up 17% (organic 11%). Adjusted operating margin was 29.7%, and the combined segment operating margin was 29.5% versus 27.5% a year earlier. Quarterly orders hit a record, with a book-to-bill ratio of 1.19:1.
On guidance, the company expects Q4 sales of $10.3 billion to $10.5 billion and adjusted EPS of $0.81 to $0.83, above the IBES consensus of $9.768 billion and $0.75; full-year sales guidance is $36.9 billion to $37.1 billion and adjusted EPS $2.82 to $2.84. The guidance excludes the three pending acquisitions of AdvancedPCB, Dexgreen and Humanetics Sensors. The company also raised its full-year sales contribution forecast for the CommScope business to $5.1 billion from $4.6 billion, and its contribution to adjusted EPS to $0.18 from $0.15.
On shareholder returns, the quarterly dividend was raised 20% to $0.15 from $0.125, payable January 13, 2027; the board approved a three-year $4 billion buyback program effective January 1, 2027, replacing the $2 billion program that will be exhausted by year-end. In Q3 the company repurchased 3 million shares for $245 million.
Related Articles

US Stock Market Move | Cryptocurrency trading revenue plunges 55% year-over-year; Robinhood (HOOD.US) falls over 4% in early trading.
.png)
Stock price soars nearly 15%! Activist investor Peltz plans to take Wendy's (WEN.US) private for US$1.4 billion.

US Stock Market Move | Genmab (GMAB.US) surged nearly 26% intraday, with its stock price hitting an all-time high.
US Stock Market Move | Cryptocurrency trading revenue plunges 55% year-over-year; Robinhood (HOOD.US) falls over 4% in early trading.

Stock price soars nearly 15%! Activist investor Peltz plans to take Wendy's (WEN.US) private for US$1.4 billion.
.png)
US Stock Market Move | Genmab (GMAB.US) surged nearly 26% intraday, with its stock price hitting an all-time high.






